| 000 | 01626 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516233513.0 | ||
| 264 | 0 | _c20160519 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.3109/0284186X.2014.952386 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHestetun, Kjersti Elvestad | |
| 245 | 0 | 0 |
_aNuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cApr 2015 |
||
| 300 |
_a470-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntimetabolites, Antineoplastic |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevamisole _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSerpins _xmetabolism |
| 650 | 0 | 4 | _aTissue Array Analysis |
| 700 | 1 | _aBrydøy, Marianne | |
| 700 | 1 | _aMyklebust, Mette Pernille | |
| 700 | 1 | _aDahl, Olav | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 54 _gno. 4 _gp. 470-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/0284186X.2014.952386 _zAvailable from publisher's website |
| 999 |
_c24196881 _d24196881 |
||